Please Sign In

HD Biosciences Co., Ltd. (HDB) is a biology-focused preclinical CRO. The company offers comprehensive service platforms in target validation, plate-based pharmacology, hit identification, lead discovery, SAR-focused MedChem, therapeutic antibody discovery, in vivo pharmacology, and DMPK/Tox. HDB collaborates with eight of the world's ten largest pharmaceutical companies and has established strategic partnership on many key R&D areas with impacts to their portfolios. Our strong scientific expertise and high quality deliverables have earned the company a great reputation in the industry and helped to build its widely recognized leadership in preclinical contract research services.